Xiaoxiao Zhang1, Yaping Yuan1,2, Sha Li1,2, Qingbin Zeng1,2, Qianni Guo1,2, Na Liu1,2, Minghui Yang1,2, Yunhuang Yang1,2, Maili Liu1,2, Michael T McMahon3,4, Xin Zhou1,2. 1. Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Collaborative Innovation Center of Chemistry for Life Sciences, Wuhan Institute of Physics and Mathematics-Wuhan National Laboratory for Optoelectronics, Chinese Academy of Sciences, Wuhan, People's Republic of China. 2. University of Chinese Academy of Sciences, Beijing, People's Republic of China. 3. The Russell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland.
Abstract
PURPOSE: CEST has become a preeminent technology for the rapid detection and grading of tumors, securing its widespread use in both laboratory and clinical research. However, many existing CEST MRI agents exhibit a sensitivity limitation due to small chemical shifts between their exchangeable protons and water. We propose a new group of CEST MRI agents, free-base porphyrins and chlorin, with large exchangeable proton chemical shifts from water for enhanced detection. METHODS: To test these newly identified CEST agents, we acquired a series of Z-spectra at multiple pH values and saturation field strengths to determine their CEST properties. The data were analyzed using the quantifying exchange using saturation power method to quantify exchange rates. After identifying several promising candidates, a porphyrin solution was injected into tumor-bearing mice, and MR images were acquired to assess detection feasibility in vivo. RESULTS: Based on the Z-spectra, the inner nitrogen protons in free-base porphyrins and chlorin resonate from -8 to -13.5 ppm from water, far shifted from the majority of endogenous metabolites (0-4 ppm) and Nuclear Overhauser enhancements (-1 to -3.5 ppm) and far removed from the salicylates, imidazoles, and anthranillates (5-12 ppm). The exchange rates are sufficiently slow to intermediate (500-9000 s-1 ) to allow robust detection and were sensitive to substituents on the porphyrin ring. CONCLUSION: These results highlight the capabilities of free-base porphyrins and chlorin as highly upfield CEST MRI agents and provide a new scaffold that can be integrated into a variety of diagnostic or theranostic agents for biomedical applications.
PURPOSE: CEST has become a preeminent technology for the rapid detection and grading of tumors, securing its widespread use in both laboratory and clinical research. However, many existing CEST MRI agents exhibit a sensitivity limitation due to small chemical shifts between their exchangeable protons and water. We propose a new group of CEST MRI agents, free-base porphyrins and chlorin, with large exchangeable proton chemical shifts from water for enhanced detection. METHODS: To test these newly identified CEST agents, we acquired a series of Z-spectra at multiple pH values and saturation field strengths to determine their CEST properties. The data were analyzed using the quantifying exchange using saturation power method to quantify exchange rates. After identifying several promising candidates, a porphyrin solution was injected into tumor-bearing mice, and MR images were acquired to assess detection feasibility in vivo. RESULTS: Based on the Z-spectra, the inner nitrogen protons in free-base porphyrins and chlorin resonate from -8 to -13.5 ppm from water, far shifted from the majority of endogenous metabolites (0-4 ppm) and Nuclear Overhauser enhancements (-1 to -3.5 ppm) and far removed from the salicylates, imidazoles, and anthranillates (5-12 ppm). The exchange rates are sufficiently slow to intermediate (500-9000 s-1 ) to allow robust detection and were sensitive to substituents on the porphyrin ring. CONCLUSION: These results highlight the capabilities of free-base porphyrins and chlorin as highly upfield CEST MRI agents and provide a new scaffold that can be integrated into a variety of diagnostic or theranostic agents for biomedical applications.
Authors: Wojciech G Lesniak; Nikita Oskolkov; Xiaolei Song; Bachchu Lal; Xing Yang; Martin Pomper; John Laterra; Sridhar Nimmagadda; Michael T McMahon Journal: Nano Lett Date: 2016-03-01 Impact factor: 11.189
Authors: Amnon Bar-Shir; Guanshu Liu; Yajie Liang; Nirbhay N Yadav; Michael T McMahon; Piotr Walczak; Sridhar Nimmagadda; Martin G Pomper; Keri A Tallman; Marc M Greenberg; Peter C M van Zijl; Jeff W M Bulte; Assaf A Gilad Journal: J Am Chem Soc Date: 2013-01-16 Impact factor: 15.419
Authors: Craig K Jones; Alan Huang; Jiadi Xu; Richard A E Edden; Michael Schär; Jun Hua; Nikita Oskolkov; Domenico Zacà; Jinyuan Zhou; Michael T McMahon; Jay J Pillai; Peter C M van Zijl Journal: Neuroimage Date: 2013-04-06 Impact factor: 6.556
Authors: Amnon Bar-Shir; Guanshu Liu; Kannie W Y Chan; Nikita Oskolkov; Xiaolei Song; Nirbhay N Yadav; Piotr Walczak; Michael T McMahon; Peter C M van Zijl; Jeff W M Bulte; Assaf A Gilad Journal: ACS Chem Biol Date: 2013-10-25 Impact factor: 5.100
Authors: Simon Walker-Samuel; Rajiv Ramasawmy; Francisco Torrealdea; Marilena Rega; Vineeth Rajkumar; S Peter Johnson; Simon Richardson; Miguel Gonçalves; Harold G Parkes; Erik Arstad; David L Thomas; R Barbara Pedley; Mark F Lythgoe; Xavier Golay Journal: Nat Med Date: 2013-07-07 Impact factor: 53.440
Authors: Kannie W Y Chan; Guanshu Liu; Xiaolei Song; Heechul Kim; Tao Yu; Dian R Arifin; Assaf A Gilad; Justin Hanes; Piotr Walczak; Peter C M van Zijl; Jeff W M Bulte; Michael T McMahon Journal: Nat Mater Date: 2013-01-27 Impact factor: 43.841